Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2013-06-03FDA Approved: ZOLEDRONIC ACID — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approves Hikma Pharmaceuticals USA Inc.'s original application for a generic zoledronic acid injectable product.
-
EMA approval · 2013-05-31European Medicines Agency recommends approval of pomalidomide for the treatment of multiple myeloma
The EMA recommends approving pomalidomide for the treatment of multiple myeloma, indicating a potential new therapy option for this disease.
-
CLINICAL_TRIALS trial_result · 2013-05-31Clinical Trial Update: Bortezomib With Melphalan and Prednisone for Multiple Myeloma [Phase 2]
Phase 2 trial investigating bortezomib with melphalan and prednisone for multiple myeloma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2013-05-31Clinical Trial Update: Combination Chemotherapy With or Without High Dose Cyclophosphamide and Recombinant Interferon Alfa-2b in Treating Patients With Previously Untreated Stage I-III Multiple Myeloma [Phase 3]
Phase 3 trial update evaluating whether adding high-dose cyclophosphamide to chemotherapy with recombinant interferon alfa-2b benefits patie…
-
CLINICAL_TRIALS research · 2013-05-21Clinical Trial Update: 89Zr-bevacizumab PET Scan in Patients With Relapsing Multiple Myeloma [NA]
This clinical trial update describes a study of 89Zr-bevacizumab PET imaging in relapsing multiple myeloma. The current trial status is unkn…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-05-16Clinical Trial Update: A Post-Approval Pharmacokinetic Study of Bortezomib in Participants With Multiple Myeloma [Phase 3]
This Phase 3 clinical trial update reports pharmacokinetic data for bortezomib in participants with multiple myeloma, conducted after initia…
-
CLINICAL_TRIALS trial_result · 2013-05-16Clinical Trial Update: Bortezomib in Treating Patients With Advanced Cancer and Kidney Dysfunction [Phase 1]
This Phase 1 trial evaluated bortezomib in patients with advanced cancer and kidney dysfunction. The study has completed.
-
CLINICAL_TRIALS trial_result · 2013-05-15Clinical Trial Update: Combination Chemotherapy in Treating Patients With Stage II or Stage III Multiple Myeloma [Phase 3]
This is an update on a Phase 3 trial evaluating combination chemotherapy for stage II/III multiple myeloma that has completed.
-
CLINICAL_TRIALS trial_result · 2013-05-10Clinical Trial Update: Combination CCI-779 (Temsirolimus) and Bortezomib (Velcade) in Relapsed and/or Relapsed/Refractory Multiple Myeloma [Phase 1, Phase 2]
Phase 1/Phase 2 trial evaluating the combination of temsirolimus (CCI-779) and bortezomib (Velcade) in relapsed or relapsed/refractory multi…
-
CLINICAL_TRIALS trial_result · 2013-05-09Clinical Trial Update: High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid Tumors [Phase 2]
Phase 2 trial evaluating high-dose chemotherapy with total-body irradiation followed by autologous stem cell or bone marrow transplantation …
-
CLINICAL_TRIALS trial_result · 2013-05-07Clinical Trial Update: A Study of Efficacy of Treatment With Bortezomib (in Combination With Doxorubicin and Dexamethasone) in Previously Untreated Patients With Multiple Myeloma [Phase 2]
Phase 2 study evaluating the efficacy of a bortezomib-based regimen (bortezomib with doxorubicin and dexamethasone) in previously untreated …
-
CLINICAL_TRIALS trial_result · 2013-05-01Clinical Trial Update: Evaluation of the Spectra Optia® Mononuclear Cell Collection Procedure [NA]
This update summarizes results from a clinical trial evaluating the Spectra Optia Mononuclear Cell Collection Procedure in multiple myeloma,…
-
CLINICAL_TRIALS trial_result · 2013-04-29Clinical Trial Update: Arsenic Trioxide and Ascorbic Acid Combined With Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia [Phase 1]
This Phase 1 trial assessed the combination of arsenic trioxide and ascorbic acid with bortezomib, thalidomide, and dexamethasone in patient…
-
CLINICAL_TRIALS trial_result · 2013-04-25Clinical Trial Update: MTD, Safety, and Efficacy of Pomalidomide (CC-4047) Alone or With Low-dose Dexamethasone in Patients With Relapsed and Refractory Multiple Myeloma [Phase 1, Phase 2]
Phase 1/2 study evaluating pomalidomide alone or with low-dose dexamethasone in relapsed/refractory multiple myeloma, reporting maximum tole…
-
CLINICAL_TRIALS trial_result · 2013-04-23Clinical Trial Update: A Phase I Study Of Thymoglobulin In Patients With Relapsed Or Refractory Multiple Myeloma [Phase 1]
Phase I study evaluating thymoglobulin in patients with relapsed or refractory multiple myeloma; the trial is completed.
-
CLINICAL_TRIALS trial_result · 2013-04-23Clinical Trial Update: BB-10901 in Treating Patients With Relapsed and/or Refractory Multiple Myeloma [Phase 1]
This document reports the completion of a Phase 1 clinical trial evaluating BB-10901 in patients with relapsed or refractory multiple myelom…
-
CLINICAL_TRIALS trial_result · 2013-04-19Clinical Trial Update: S0417 Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma [Phase 2]
Phase 2 trial of bortezomib, thalidomide, and dexamethasone in relapsed or refractory multiple myeloma; study terminated with results posted…
-
CLINICAL_TRIALS trial_result · 2013-04-18Clinical Trial Update: Preventive Treatment of VETD in Patients With Multiple Myeloma Receiving Chemotherapy With Thalidomide or Lenalinomide.
A completed clinical trial evaluating preventive treatment for VETD in patients with multiple myeloma receiving thalidomide- or lenalidomide…
-
CLINICAL_TRIALS trial_result · 2013-04-18Clinical Trial Update: Studying Fentanyl in Patients With Cancer
A Johns Hopkins cancer center trial evaluating fentanyl in cancer patients has been terminated. The study encompassed multiple cancer-relate…
-
CLINICAL_TRIALS other · 2013-04-16Clinical Trial Update: Expanded Access Protocol (EAP) to Provide Bortezomib to Patients With Multiple Myeloma Who Have Received at Least 2 Previous Lines of Therapy and Are Refractory to or Have Relapsed After Their Last Therapy for Multiple Myeloma
This document describes an Expanded Access Protocol to provide Bortezomib to multiple myeloma patients who have received at least two prior …
-
CLINICAL_TRIALS trial_result · 2013-04-11Clinical Trial Update: Whole Body Diffusion Weighted Magnetic Resonance Imaging (DW-MRI) in Multiple Myeloma [NA]
A completed clinical trial assesses the use of whole-body diffusion-weighted MRI in patients with multiple myeloma.
-
CLINICAL_TRIALS trial_result · 2013-04-09Clinical Trial Update: Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma [Phase 2]
A Phase 2 clinical trial update evaluating chemotherapy plus bone marrow transplantation in patients with refractory non-Hodgkin lymphoma, H…
-
CLINICAL_TRIALS trial_result · 2013-04-05Clinical Trial Update: Bryostatin 1 in Treating Patients With Relapsed Multiple Myeloma [Phase 2]
Bryostatin-1 was studied in patients with relapsed multiple myeloma. The Phase 2 study has completed.
-
CLINICAL_TRIALS research · 2013-04-05Clinical Trial Update: Study of Bendamustine, Lenalidomide and Low-dose Dexamethasone, for the Treatment of Patients With Relapsed Myeloma [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating bendamustine, lenalidomide, and low-dose dexamethasone for relapsed multiple myeloma; status is unknow…
-
CLINICAL_TRIALS withdrawal · 2013-04-05Clinical Trial Update: Ex-Vivo Depletion of Myeloma Cells From Peripheral Blood Progenitor Cell Grafts [Phase 2]
A Phase 2 trial evaluating ex-vivo depletion of myeloma cells from peripheral blood progenitor cell grafts in multiple myeloma has been with…